Fear-Avoidance Behavior and Physical Deconditioning When your back hurts, you naturally want to avoid movements that cause pain
In October 2024, the FDA declared that tirzepatide was no longer in shortage, and shortly after in February 2025 announced the same for semaglutide
Summary In summary, GLP-1 RA based therapies are being rigorously studied in management of MASLD in particular more advanced stages and likely will become foundational therapies in the future
The question of whether GLP-1 medications directly affect kidney health is addressed in our guide on semaglutide and kidney stones , which covers principles relevant to all medications in this class
Your workouts feel harder than they should
For women of reproductive age, the relationship between GLP-1 receptor agonists and reproductive hormones is an area of active research